Placebo-controlled cross-over study of the monoaminergic stabiliser (-)-OSU6162 in mental fatigue following stroke or traumatic brain injury

Acta Neuropsychiatrica

Volumn 24, Issue 5, 2012, Pages 266-274

  Johansson, Birgitta ^a   Carlsson, Arvid ^a   Carlsson, Maria L ^a   Karlsson, Magdalena ^a   Nilsson, Marie K L ^a   Nordquist Brandt, Elisabeth ^a   Rönnbäck, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

brain injuries; drug therapy; mental fatigue; stroke

Indexed keywords

3 [3 (METHYLSULFONYL)PHENYL] 1 PROPYLPIPERIDINE;

ADULT; APPETITE; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSTHYMIA; FEMALE; HUMAN; MALE; NAUSEA; PRINCIPAL COMPONENT ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STROKE; TRAUMATIC BRAIN INJURY;

EID: 84866513230     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2012.00678.x     Document Type: Article

References (36)

1. Chaudhuri A, Behan PO,. Fatigue in neurological disorders. Lancet 2004; 363: 978-988.
2. Deluca J,. Fatigue as a window to the brain. Cambridge, Massachusetts, London, England: A Bradford Book, The MIT Press, 2005.
3. Rödholm M, Starmark J-E, Svensson E, Von Essen C,. Asteno-emotional disorder after aneurysmal SAH: reliability, symptomatology and relation to outcome. Acta Neurol Scand 2001; 103: 379-385.
4. Rönnbäck L, Hansson E,. On the potential role of glutamate transport in mental fatigue. J Neuroinflammation 2004; 1: 22.
5. Lindqvist G, Malmgren H,. Organic mental disorders as hypothetical pathogenetic processes. Acta Psychiatr Scand 1993; 88 (Suppl. 373): 5-17.
6. Staub F, Bogousslavsky J,. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 2001; 12: 75-81.
7. Belmont A, Agar N, Hugeron C, Gallais B, Azouvi P,. Fatigue and traumatic brain injury. Ann Readapt Med Phys 2006; 49: 283-288.
8. Kohl AD, Wylie GR, Genova HM, Hillary F, Deluca J,. The neural correlates of cognitive fatigue in traumatic brain injury using functional MRI. Brain Inj 2009; 23: 420-432.
9. Ziino C, Ponsford J,. Vigilance and fatigue following traumatic brain injury. J Int Neuropsychol Soc 2006; 12: 100-110.
10. Ashman TA, Cantor JB, Gordon WA, et al. Objective measurement of fatigue following traumatic brain injury. J Head Trauma Rehabil 2008; 23: 33-40.
11. Johansson B, Berglund P, Rönnbäck L,. Mental fatigue and impaired information processing after mild and moderate traumatic brain injury. Brain Inj 2009; 23 (13-14): 1027-1040.
12. Johansson B, Rönnbäck L,. Mental fatigue: a common long term consequence after a brain injury. In:, Agrawal A, ed. Brain injury-functional aspects, rehabilitation and prevention. Rijeka, Croatia: InTech, 2012: 3-16.
13. Brennan AR, Arnsten FT,. Neuronal mechanisms underlying attention deficit hyperactivity disorder. Ann N Y Acad Sci 2008; 1129: 236-245.
14. Posner IM, Rothbart MK,. Research on attention networks as a model for the integration of psychological science. Annu Rev Psychol 2007; 58: 1-23.
15. Azmitia EC,. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 1999; 21 (Suppl. 2): 33S-45S.
16. Rung JP, Rung E, Helgeson L, et al. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. J Neural Transm 2008; 115: 899-908.
17. Lahti R, Tamminga CA, Carlsson A,. Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D(2) receptor function in vitro. J Neural Transm 2007; 114: 1143-1146.
18. Ekesbo A, Andrén PE, Gunne LM, Tedroff J,. (-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Neuroreport 1997; 8: 2567-2570.
19. Tedroff J, Ekesbo A, Rydin E, Sonesson S, Waters N, Carlsson A,. Clinical effects of (-)-OSU6162 in very advanced Parkinson's disease. A study report to the Swedish Medical Products Agency, March 9, 2000.
20. Tedroff J, Ekesbo A, Sonesson S, Waters N, Carlsson A,. Long-lasting improvement following (-)-OSU6162 in patients with Huntington's disease. Neurology 1999; 53: 1605-1606.
21. Gefvert O, Lindström LH, Dahlbäck O, et al. (-)-OSU6162 induces a rapid onset of antipsychotic effect after a single dose. A double-blind placebo-controlled pilot study. Scandinavian Society for Psychopharmacology 41st annual meeting, Copenhagen, Denmark. Nord J Psychiatry 2000; 54: 93-94.
22. Lundberg T, Tedroff J, Waters N, et al. Safety of early clinical experience with (-)-OSU6162, a dopaminergic stabilizer with antipsychotic properties. In: SCNP 43rd Annual and 2nd Mediterranean Meeting, Juan-les-Pins, France. Nord J Psychiatry 2002; 56: 24.
23. Burstein ES, Carlsson ML, Owens M, et al. II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors. J Neural Transm 2011; 118: 1523-1533.
24. Carlsson ML, Burstein ES, Kloberg A, et al. I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors. J Neural Transm 2011; 118: 1511-1522.
25. Rodríguez CA, Azie NE, Adams G, et al. Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 (=OSU6162) in healthy volunteers. J Clin Pharmacol 2004; 44: 276-283.
26. Johansson B, Starmark A, Berglund P, Rödholm M, Rönnbäck L,. A self-assessment questionnaire for mental fatigue and related symptoms after neurological disorders and injuries. Brain Inj 2010; 24: 2-12.
27. Rönnbäck L, Johansson B,. Long-lasting mental fatigue after traumatic brain injury or stroke-a new perspective. Saarbrucken: LAP Lambert Academic Publishing, 2012.
28. Svanborg P, Åsberg M,. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1994; 89: 21-28.
29. Åsberg M, Montgomery SA, Perris C, Schalling D, Sedvall G,. A comprehensive psychopathological rating scale. Acta Psychiatr Scand 1978; 271 (Suppl): 5-27.
30. Holbrook M, Skilbeck CE,. An activity index for use with stroke patients. Age Aging 1983; 12: 166-170.
31. Wechsler D,. Wechsler Adult Intelligence Scale (WAIS-III). 3rd edn in Swedish Stockholm: Pearson Assessment, 2003.
32. Ellis DC, Kaplan E, Kramer JH,. Delis-Kaplan Executive Function System-D-KEFS. San Antonio, TX: The Psychological Corporation, 2001.
33. Reitan RM, Wolfson D,. The Halstead-Reitan neuropsychological test battery. Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press, 1985.
34. Madison S,. Läsdiagnos. Lund: Läs och skrivcentrum, 2003.
35. Johansson B, Rönnbäck L,. Mental fatigue and cognitive impairment after an almost neurological recovered stroke. ISRN Psychiatry 2012. [E-pub ahead of print; DOI: 10.5402/2012/686425].
36. Senn S,. Cross-over trials in clinical research. 2nd edn. Chichester: Wiley, 2002.